Vertaling van "active ingredient " (Nederlands → Frans) :

TERMINOLOGIE

activator voor tandheelkundige polymerisatie
lampe de polymérisation dentaire/chirurgicale

IN-CONTEXT TRANSLATIONS

The active ingredient, everolimus, is the same as in the transplant therapy Certican.
Evérolimus est la substance active de Certican, un traitement utilisé dans les transplantations.

The active ingredient of this medicine is covered by a compound patent that expires in 2010 in the US.
La substance active de ce médicament est couverte par un brevet qui expire en 2010 dans ce pays.

●● Efficacy: the active ingredient is as such subject to an authorisation or prequalification by the WHO or a positive opinion from the EMEA During this first year of activity, The Production & Distribution department issued 149 EDs.
●● Efficacy: the active ingredient is as such subject to an authorisation or prequalification by the WHO or a positive opinion from the EMEA During this first year of activity, The Production & Distribution department issued 149 EDs.

Active pharmacovigilance In the context of the FAMHP’s decision to promote proactive pharmacovigilance, a decision was made at the end of 2007 to encourage healthcare professionals to pay extra attention to adverse effects that arise after taking medicines with a new active ingredient (the “black triangle” project - during
Active pharmacovigilance In the context of the FAMHP’s decision to promote proactive pharmacovigilance, a decision was made at the end of 2007 to encourage healthcare professionals to pay extra attention to adverse effects that arise after taking medicines with a new active ingredient (the “black triangle” project - during

medicines for human use and veterinary medicines, raw materials (active ingredients) for pharmacists, establishment of retail pharmacies, medical devices) ●● Management of possible crisis situations ●● Coordination of the (inter)national representation of the FAMHP ●● The difference between the roles of “Communication” versus “Information” ●● Points of entry for applications submitted to
medicines for human use and veterinary medicines, raw materials (active ingredients) for pharmacists, establishment of retail pharmacies, medical devices) ●● Management of possible crisis situations ●● Coordination of the (inter)national representation of the FAMHP ●● The difference between the roles of “Communication” versus “Information” ●● Points of entry for applications submitted to

Our production processes are optimized so as to minimize the release of active ingredients into the environment.
De même, nous optimisons nos méthodes de production de sorte à minimiser le rejet de substances actives dans l’environnement.

We adopt a risk-based approach and focus on minimizing our use of natural resources, cutting our energy consumption and emissions, and preventing active ingredients from entering the environment.
Notre approche est basée sur une évaluation des risques ; nous nous efforçons de réduire au minimum notre exploitation des ressources naturelles, d’abaisser notre consommation d’énergie et nos émissions de gaz polluants dans l’air, et nous prenons toutes les mesures adéquates pour empêcher les émanations de substances actives en dehors de nos laboratoires.

De buitendiensten van Unit II inspecteren de geneesmiddelenfabrikanten (in België en in derde landen), verdelers, groothandelaar-verdelers, erkende laboratoria, bedrijven erkend op basis van het koninklijk besluit betreffende grondstoffen gebruikt door de officina-apotheker, de producenten van “Active Pharmaceutical Ingredient” (API) en de bloed-, cel- en weefselbanken.
Les services extérieurs de l’Unité II inspectent les fabricants de médicaments (en Belgique et dans les pays tiers), les distributeurs, les grossistesrépartiteurs, les laboratoires agréés, les sociétés agréés sur base de l’arrêté royal relatif aux matières premières utilisées par les pharmaciens d’officine, les producteurs des « Active Pharmaceutical Ingredient » (API) et les banques de sang, cellules et tissus.

Diverse aspecten werden uitgewerkt zoals de veiligheidskenmerken, Active Pharmaceutical Ingredients (API), het statuut van actoren in de distributieketen en internetverkoop van geneesmiddelen.
Divers aspects ont été développés tels que les caractéristiques de sécurité, les Active Pharmaceutical Ingredients (API), le statut des acteurs dans la chaîne de distribution ou la vente de médicaments sur internet.

The external services of Unit II inspect manufacturers of medicines (in Belgium and non-EU countries), the wholesalers, the recognised laboratories, the companies recognised on the basis of the royal decree on raw materials used by the pharmacist, the manufacturers of “Active Pharmaceutical Ingredient” (API), blood establishments and cell and tissue banks.
The external services of Unit II inspect manufacturers of medicines (in Belgium and non-EU countries), the wholesalers, the recognised laboratories, the companies recognised on the basis of the royal decree on raw materials used by the pharmacist, the manufacturers of “Active Pharmaceutical Ingredient” (API), blood establishments and cell and tissue banks.